Pliant Therapeutics Inc

Pliant Therapeutics Inc(PLRX)价格预测

$0.806

-0.009 (-1.16%)收盘时

价格预测

1-Day Price Prediction
-0.70%
1-Week Prediction
-3.53%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

在 App 中打开以解锁更长周期的预测。

Loading chart…

PLRX 相似图表分析预测

Alphio's PLRX stock price prediction model matches the current Pliant Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.80 (-0.70%). The 1-week path is $0.78 (-3.53%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

该买入 Pliant Therapeutics Inc 股票吗?

Pliant Therapeutics Inc is currently trading at $0.8392, which is very close to its 52-week low of $0.83. The RSI is at 30.592, indicating that the stock is oversold, but the company continues to report significant losses, with a net income loss of $23.577 million in Q4 2025. While there are some positive developments in their oncology focus, the overall financial performance and recent stock decline suggest caution. The main risk is the company's ongoing negative earnings, with an EPS of -0.36 reported last quarter, which raises concerns about its profitability moving forward.

PLRX 股价于 Friday 收于 $0.81,此前下跌 -1.16%

Pliant Therapeutics Inc (PLRX) last closed at $0.8063, losing -1.16%. These facts feed the 1-day and 1-week PLRX price prediction above.

预测驱动因素

Pliant Therapeutics Inc(PLRX)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

相似图表形态

近期走势与 PLRX 最接近的股票,按相似度排序。

PLRX 季节性分析

Historically the probability of a positive November return for PLRX is 0.00%. January offers the highest probability of a positive month at 37.70%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易